These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 17570739)

  • 1. Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics.
    Gan SH; Ismail R; Wan Adnan WA; Zulmi W
    Mol Diagn Ther; 2007; 11(3):171-81. PubMed ID: 17570739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol.
    Kirchheiner J; Keulen JT; Bauer S; Roots I; Brockmöller J
    J Clin Psychopharmacol; 2008 Feb; 28(1):78-83. PubMed ID: 18204346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the cytochrome P450 2D6*10 genotype on the pharmacokinetics of tramadol in post-operative patients.
    Xu J; Zhang XC; Lv XQ; Xu YY; Wang GX; Jiang B; Cai L; Cai XJ
    Pharmazie; 2014 Feb; 69(2):138-41. PubMed ID: 24640604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.
    Kirchheiner J; Schmidt H; Tzvetkov M; Keulen JT; Lötsch J; Roots I; Brockmöller J
    Pharmacogenomics J; 2007 Aug; 7(4):257-65. PubMed ID: 16819548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of tramadol on static and dynamic pupillometry in healthy subjects--the relationship between pharmacodynamics, pharmacokinetics and CYP2D6 metaboliser status.
    Fliegert F; Kurth B; Göhler K
    Eur J Clin Pharmacol; 2005 Jun; 61(4):257-66. PubMed ID: 15906019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2D6 polymorphism in relation to tramadol metabolism: a study of faroese patients.
    Halling J; Weihe P; Brosen K
    Ther Drug Monit; 2008 Jun; 30(3):271-5. PubMed ID: 18520597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes.
    Stamer UM; Musshoff F; Kobilay M; Madea B; Hoeft A; Stuber F
    Clin Pharmacol Ther; 2007 Jul; 82(1):41-7. PubMed ID: 17361124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.
    Zhou SF
    Clin Pharmacokinet; 2009; 48(12):761-804. PubMed ID: 19902987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid and simple CYP2D6 genotyping assay--case study with the analgetic tramadol.
    Borlak J; Hermann R; Erb K; Thum T
    Metabolism; 2003 Nov; 52(11):1439-43. PubMed ID: 14624403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tramadol as a new probe for cytochrome P450 2D6 phenotyping: a population study.
    Pedersen RS; Damkier P; Brosen K
    Clin Pharmacol Ther; 2005 Jun; 77(6):458-67. PubMed ID: 15961977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Miotic action of tramadol is determined by CYP2D6 genotype.
    Slanar O; Nobilis M; Kvetina J; Mikoviny R; Zima T; Idle JR; Perlík F
    Physiol Res; 2007; 56(1):129-136. PubMed ID: 16497087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of CYP2D6 genotype on postoperative tramadol analgesia.
    Stamer UM; Lehnen K; Höthker F; Bayerer B; Wolf S; Hoeft A; Stuber F
    Pain; 2003 Sep; 105(1-2):231-8. PubMed ID: 14499440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of tramadol pharmacokinetics and CYP2D6*10 genotype in Malaysian subjects.
    Gan SH; Ismail R; Wan Adnan WA; Wan Z
    J Pharm Biomed Anal; 2002 Sep; 30(2):189-195. PubMed ID: 12191703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.
    Stamer UM; Zhang L; Book M; Lehmann LE; Stuber F; Musshoff F
    PLoS One; 2013; 8(3):e60239. PubMed ID: 23555934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tramadol efficacy in patients with postoperative pain in relation to CYP2D6 and MDR1 polymorphisms.
    Slanar O; Dupal P; Matouskova O; Vondrackova H; Pafko P; Perlik F
    Bratisl Lek Listy; 2012; 113(3):152-5. PubMed ID: 22428763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the CYP2D6 gene polymorphism on postoperative analgesia of tramadol in Han nationality nephrectomy patients.
    Dong H; Lu SJ; Zhang R; Liu DD; Zhang YZ; Song CY
    Eur J Clin Pharmacol; 2015 Jun; 71(6):681-686. PubMed ID: 25948472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of tramadol enantiomers and their respective phase I metabolites in relation to CYP2D6 phenotype.
    García-Quetglas E; Azanza JR; Sádaba B; Muñoz MJ; Gil I; Campanero MA
    Pharmacol Res; 2007 Feb; 55(2):122-30. PubMed ID: 17175164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP2D6 polymorphism, tramadol pharmacokinetics and pupillary response.
    Slanar O; Nobilis M; Kvetina J; Idle JR; Perlík F
    Eur J Clin Pharmacol; 2006 Jan; 62(1):75-6; author reply 77-8. PubMed ID: 16283276
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.
    Zineh I; Beitelshees AL; Gaedigk A; Walker JR; Pauly DF; Eberst K; Leeder JS; Phillips MS; Gelfand CA; Johnson JA
    Clin Pharmacol Ther; 2004 Dec; 76(6):536-44. PubMed ID: 15592325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6) are associated with long term tramadol treatment-induced oxidative damage and hepatotoxicity.
    Arafa MH; Atteia HH
    Toxicol Appl Pharmacol; 2018 May; 346():37-44. PubMed ID: 29555325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.